Keros Therapeutics, Inc. (KROS)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 10:44AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 2.17B |
| Enterprise Value | 1.86B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 11.75k |
| Price/Book (mrq) | 6.54 |
| Enterprise Value/Revenue | 12.30k |
| Enterprise Value/EBITDA | -12.20 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.27 |
| 52-Week Change 3 | 36.18% |
| S&P500 52-Week Change 3 | 25.77% |
| 52 Week High 3 | 73.00 |
| 52 Week Low 3 | 27.02 |
| 50-Day Moving Average 3 | 63.18 |
| 200-Day Moving Average 3 | 44.84 |
Share Statistics
| Avg Vol (3 month) 3 | 353.15k |
| Avg Vol (10 day) 3 | 339.4k |
| Shares Outstanding 5 | 36.07M |
| Implied Shares Outstanding 6 | 36.25M |
| Float 8 | 30.85M |
| % Held by Insiders 1 | 6.36% |
| % Held by Institutions 1 | 87.87% |
| Shares Short (Apr 15, 2024) 4 | 2.26M |
| Short Ratio (Apr 15, 2024) 4 | 6.49 |
| Short % of Float (Apr 15, 2024) 4 | 8.92% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 6.26% |
| Shares Short (prior month Mar 15, 2024) 4 | 1.92M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -32,486.01% |
Management Effectiveness
| Return on Assets (ttm) | -31.39% |
| Return on Equity (ttm) | -50.19% |
Income Statement
| Revenue (ttm) | 151k |
| Revenue Per Share (ttm) | 0.00 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -169.13M |
| Net Income Avi to Common (ttm) | -152.99M |
| Diluted EPS (ttm) | -5.20 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 331.15M |
| Total Cash Per Share (mrq) | 9.2 |
| Total Debt (mrq) | 14.44M |
| Total Debt/Equity (mrq) | 4.35% |
| Current Ratio (mrq) | 14.25 |
| Book Value Per Share (mrq) | 10.43 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -124.51M |
| Levered Free Cash Flow (ttm) | -81.25M |
© 2024 Yahoo. All rights reserved.